Enhances transparency in the prescription drug supply chain by requiring disclosure of drug origin, manufacture, and distribution information.

The Foreign Drug Transparency Act aims to increase transparency in the prescription drug supply chain by mandating that pharmacy benefit managers maintain and provide supply chain information for prescription drugs. This includes details such as the country of origin, active pharmaceutical ingredients, and the names and locations of manufacturers, packers, and distributors. Pharmacies must ensure that this information is accessible to patients at the point of dispensing, either through a clearly visible notation on the prescription label, a machine-readable code, or a digital link.

Enhances transparency in the prescription drug supply chain by requiring disclosure of drug origin, manufacture, and distribution information.

The Foreign Drug Transparency Act aims to increase transparency in the prescription drug supply chain by mandating that pharmacy benefit managers maintain and provide supply chain information for prescription drugs. This includes details such as the country of origin, active pharmaceutical ingredients, and the names and locations of manufacturers, packers, and distributors. Pharmacies must ensure that this information is accessible to patients at the point of dispensing, either through a clearly visible notation on the prescription label, a machine-readable code, or a digital link.